Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-05-01 | Mr. Peter Thornton, age 52, is the Chief Financial Officer of Technopath Clinical Diagnostics, an Irish company that provides quality control materials and software solutions to clinical laboratories, a position he has held since January 2014. It is anticipated that, upon election to our Board, he will join the Audit Committee as its Chairman, and would join the Nominating and Corporate Governance Committee as a member. |
| 2018-05-17 | Mr. Peter Thornton, age 53, is the Chief Financial Officer of Technopath Clinical Diagnostics... Committees: (2*)(3) where (2*) Chairman of the Audit Committee, (3) Member of the Nominating and Corporate Governance Committee. Director compensation table shows total compensation of $280,908. |
| 2019-04-30 | Mr. Peter Thornton, age 54, has been a member of the Board of Directors since June 2017... Mr. Thornton brings to the Board, Audit Committee and the Nominating and Corporate Governance Committee over 26 years of experience. |
| 2020-04-27 | Peter Thornton, 55, has been a member of the Board of Directors since June 2017. He is the Chief Financial Officer of Technopath Clinical Diagnostics, an Irish company that provides quality control materials and software solutions to clinical laboratories worldwide, a position he has held since January 2014. Prior to joining Technopath Clinical Diagnostics, from September 2011 to December 2013, Mr. Thornton was Senior Vice President — Business Integration for Alkermes plc, a global biopharmaceuticals company headquartered in Dublin, Ireland. |
Data sourced from SEC filings. Last updated: 2026-02-08